(Q34548111)

2 August 2017

1 reference

title

The future of polio eradication (English)

1 reference

2 August 2017

H F Hull

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

299-303

1 reference

Paralytic poliomyelitis: seasoned strategies, disappearing disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Plans to eradicate polio hit by virus outbreak in Bulgaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Outbreak of poliomyelitis in Angola

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

1 reference

7 January 2021

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Invited commentary: The scientific basis for stopping polio immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

Detection of Poliovirus Antibodies and Poliovirus Genome in Patients with the Post‐Polio Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

1 reference

7 January 2021

Biosafety consequences of eradication of wild-type polioviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900143-8

7 January 2021

10.1016/S1473-3099(01)00143-8

Identifiers

DOI

1 reference

2 August 2017

1 reference